Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Gilead Sciences
GILD
$162B
| $175M | 0.13% |
2,037,950
-2,226,690
| -52% | -$176M |
|
177
Schwab US Large- Cap ETF
SCHX
$71.1B
| $175M | 0.13% |
11,623,893
-11,318,727
| -49% | -$171M |
|
178
Jazz Pharmaceuticals
JAZZ
$16B
| $175M | 0.12% |
1,096,843
-1,380,957
| -56% | -$202M |
|
179
Magnolia Oil & Gas
MGY
$5.53B
| $171M | 0.12% |
7,277,341
-8,000,091
| -52% | -$195M |
|
180
Cullen/Frost Bankers
CFR
$10.3B
| $167M | 0.12% |
1,250,832
-571,232
| -31% | -$81.2M |
|
|
FOLD
181
DELISTED
Amicus Therapeutics
FOLD
| $167M | 0.12% |
13,694,549
-15,857,681
| -54% | -$179M |
|
182
Sempra
SRE
$59.7B
| $167M | 0.12% |
2,159,252
-2,081,860
| -49% | -$161M |
|
183
STAG Industrial
STAG
$7.77B
| $166M | 0.12% |
5,125,233
-3,742,447
| -42% | -$117M |
|
184
Blackbaud
BLKB
$1.59B
| $165M | 0.12% |
2,807,524
-2,793,236
| -50% | -$156M |
|
185
TSMC
TSM
$2.07T
| $163M | 0.12% |
2,191,006
-2,200,784
| -50% | -$159M |
|
186
Ryan Specialty Holdings
RYAN
$5.59B
| $163M | 0.12% |
3,923,601
-3,868,025
| -50% | -$158M |
|
|
AXON
187
Axon Enterprise
AXON
$42.4B
| $163M | 0.12% |
979,882
-1,157,730
| -54% | -$183M |
|
188
Cencora
COR
$60.5B
| $158M | 0.11% |
955,658
-988,066
| -51% | -$156M |
|
189
Walker & Dunlop
WD
$1.69B
| $157M | 0.11% |
2,003,321
-1,923,521
| -49% | -$162M |
|
|
PXD
190
DELISTED
Pioneer Natural Resource Co.
PXD
| $157M | 0.11% |
686,545
-1,023,087
| -60% | -$249M |
|
191
Occidental Petroleum
OXY
$54.6B
| $151M | 0.11% |
2,402,739
-2,410,397
| -50% | -$164M |
|
192
Core & Main
CNM
$8.17B
| $151M | 0.11% |
7,812,849
-7,931,419
| -50% | -$169M |
|
193
Integra LifeSciences
IART
$1.52B
| $148M | 0.11% |
2,638,059
-3,707,017
| -58% | -$189M |
|
194
Elanco Animal Health
ELAN
$12.7B
| $146M | 0.1% |
11,977,855
-12,135,537
| -50% | -$151M |
|
|
195
TFI International
TFII
$12B
| $146M | 0.1% |
1,455,195
+1,451,995
| +45,375% | +$145M |
|
196
OSI Systems
OSIS
$3.58B
| $146M | 0.1% |
1,832,332
-1,782,684
| -49% | -$145M |
|
197
Yum China
YUMC
$15.3B
| $143M | 0.1% |
2,558,353
-3,105,047
| -55% | -$158M |
|
198
Intuit
INTU
$83.1B
| $140M | 0.1% |
359,965
-639,841
| -64% | -$254M |
|
199
Waters Corp
WAT
$36.4B
| $139M | 0.1% |
404,437
-435,675
| -52% | -$138M |
|
200
Euronet Worldwide
EEFT
$3.01B
| $138M | 0.1% |
1,461,978
-1,454,542
| -50% | -$126M |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.